Free Trial

Morgan Stanley (MS) Projected to Post Earnings on Wednesday

Morgan Stanley logo with Finance background

Morgan Stanley (NYSE:MS - Get Free Report) is projected to post its Q2 2025 quarterly earnings results before the market opens on Wednesday, July 16th. Analysts expect Morgan Stanley to post earnings of $2.01 per share and revenue of $16.15 billion for the quarter.

Morgan Stanley (NYSE:MS - Get Free Report) last released its earnings results on Friday, April 11th. The financial services provider reported $2.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.21 by $0.39. Morgan Stanley had a return on equity of 14.98% and a net margin of 12.98%. The company had revenue of $17.74 billion for the quarter, compared to analysts' expectations of $16.81 billion. During the same quarter in the previous year, the firm posted $2.02 EPS. The firm's quarterly revenue was up 17.2% on a year-over-year basis. On average, analysts expect Morgan Stanley to post $9 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Morgan Stanley Stock Performance

NYSE MS traded up $0.44 on Wednesday, hitting $141.57. 4,836,698 shares of the company's stock were exchanged, compared to its average volume of 6,693,920. The company has a debt-to-equity ratio of 3.11, a current ratio of 0.78 and a quick ratio of 0.78. The firm's 50-day moving average price is $130.63 and its two-hundred day moving average price is $126.37. Morgan Stanley has a fifty-two week low of $90.94 and a fifty-two week high of $145.16. The firm has a market cap of $227.12 billion, a price-to-earnings ratio of 16.62, a P/E/G ratio of 1.32 and a beta of 1.30.

Morgan Stanley Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Wednesday, April 30th were given a dividend of $0.925 per share. This represents a $3.70 annualized dividend and a yield of 2.61%. The ex-dividend date was Wednesday, April 30th. Morgan Stanley's payout ratio is 43.43%.

Morgan Stanley announced that its Board of Directors has approved a share repurchase plan on Tuesday, July 1st that authorizes the company to buyback $20.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to reacquire up to 8.9% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board believes its shares are undervalued.

Wall Street Analyst Weigh In

MS has been the topic of a number of analyst reports. The Goldman Sachs Group increased their target price on Morgan Stanley from $121.00 to $136.00 and gave the company a "neutral" rating in a report on Tuesday, June 10th. Evercore ISI reduced their price target on Morgan Stanley from $150.00 to $138.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 1st. JMP Securities reissued a "market perform" rating on shares of Morgan Stanley in a research note on Monday, April 14th. Keefe, Bruyette & Woods raised Morgan Stanley from a "market perform" rating to an "outperform" rating and increased their price target for the stock from $127.00 to $160.00 in a research note on Wednesday. Finally, Wells Fargo & Company increased their price target on Morgan Stanley from $120.00 to $145.00 and gave the stock an "equal weight" rating in a research note on Tuesday. Ten equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Morgan Stanley presently has a consensus rating of "Hold" and a consensus price target of $136.69.

Read Our Latest Analysis on MS

Insider Activity

In related news, insider Eric F. Grossman sold 10,068 shares of Morgan Stanley stock in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $111.65, for a total value of $1,124,092.20. Following the completion of the transaction, the insider directly owned 199,274 shares in the company, valued at approximately $22,248,942.10. This trade represents a 4.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert H. Herz sold 800 shares of Morgan Stanley stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $119.32, for a total value of $95,456.00. Following the completion of the transaction, the director owned 96,760 shares of the company's stock, valued at $11,545,403.20. This trade represents a 0.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,868 shares of company stock worth $6,019,548 over the last ninety days. Corporate insiders own 0.19% of the company's stock.

Hedge Funds Weigh In On Morgan Stanley

A hedge fund recently raised its stake in Morgan Stanley stock. Brighton Jones LLC grew its holdings in shares of Morgan Stanley (NYSE:MS - Free Report) by 10.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,782 shares of the financial services provider's stock after buying an additional 1,185 shares during the period. Brighton Jones LLC's holdings in Morgan Stanley were worth $1,607,000 as of its most recent filing with the Securities and Exchange Commission. 84.19% of the stock is owned by institutional investors and hedge funds.

Morgan Stanley Company Profile

(Get Free Report)

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.

Featured Articles

Earnings History for Morgan Stanley (NYSE:MS)

Should You Invest $1,000 in Morgan Stanley Right Now?

Before you consider Morgan Stanley, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.

While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines